Catalyst Biosciences, Inc. (CBIO) financial statements (2022 and earlier)

Company profile

Business Address 611 GATEWAY BLVD., SUITE 710
SOUTH SAN FRANCISCO, CA 94080
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:46,90081,90076,900120,10032,40017,10032,500
Cash and cash equivalents44,34730,36015,36931,21314,47210,26429,096
Short-term investments2,50448,99461,49688,91417,9716,8003,402
Other undisclosed cash, cash equivalents, and short-term investments492,54635(27)(43)362
Restricted cash and investments   505,33319,46833,794
Receivables1,8183,31315,000 2431492
Deposits current assets      133
Other undisclosed current assets2,7584,2974,1663,8411,3529221,779
Total current assets:51,47689,51096,066123,99139,10937,52168,698
Noncurrent Assets
Operating lease, right-of-use asset2,7441,8321,927
Property, plant and equipment970433304386276444698
Long-term investments and receivables 2,543     
Long-term investments 2,543     
Deposits noncurrent assets    128  
Restricted cash and investments     125125
Other noncurrent assets472528257543   
Total noncurrent assets:4,1865,3362,488929404569823
TOTAL ASSETS:55,66294,84698,554124,92039,51338,09069,521
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,95815,15013,4164,7863,4352,2382,400
Accounts payable6,4195,9314,2791,248747837939
Accrued liabilities4,0726,7437,0312,0431,322805535
Employee-related liabilities1,4672,4762,1061,4951,366596926
Deferred revenue2301,98315,000
Debt  483 5,08519,40333,743
Deferred rent credit   15
Derivative instruments and hedges, liabilities      1,156
Deferred revenue and credits219324457
Other undisclosed current liabilities1,977663     
Total current liabilities:14,16517,79628,8994,8018,73921,96537,756
Noncurrent Liabilities
Long-term debt and lease obligation4089811,319    
Operating lease, liability4089811,319
Liabilities, other than long-term debt   174 54340
Deferred revenue and credits 54340
Deferred rent credit   174
Other undisclosed noncurrent liabilities(408)(981)     
Total noncurrent liabilities:4089811,319174 54340
Total liabilities:14,57318,77730,2184,9758,73922,01938,096
Stockholders' equity
Stockholders' equity attributable to parent41,08976,06968,336119,94530,77416,07131,425
Common stock312212126111
Additional paid in capital443,752390,803326,810323,279204,262164,053162,450
Accumulated other comprehensive income (loss) 534(4) (1)1
Accumulated deficit(402,694)(314,761)(258,520)(203,342)(173,494)(147,982)(131,037)
Total stockholders' equity:41,08976,06968,336119,94530,77416,07131,425
TOTAL LIABILITIES AND EQUITY:55,66294,84698,554124,92039,51338,09069,521

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues7,33820,948 61,0183991,750
Revenue, net1,0183991,750
Gross profit:7,33820,948 61,0183991,750
Operating expenses(95,232)(78,318)(57,277)(33,828)(22,840)(20,817)(15,552)
Operating loss:(87,894)(57,370)(57,277)(33,822)(21,822)(20,418)(13,802)
Nonoperating income (expense)(87)659(39)1,65426186 
Other nonoperating income (expense)(87)659(39)1,65026186 
Interest and debt expense     99(1,478)
Loss before gain (loss) on sale of properties:(87,981)(56,711)(57,316)(32,168)(21,561)(20,233)(15,280)
Other undisclosed net income484702,1382,113   
Net loss:(87,933)(56,241)(55,178)(30,055)(21,561)(20,233)(15,280)
Other undisclosed net income attributable to parent     3,288518
Net loss attributable to parent:(87,933)(56,241)(55,178)(30,055)(21,561)(16,945)(14,762)
Preferred stock dividends and other adjustments    (3,951)  
Net loss available to common stockholders, diluted:(87,933)(56,241)(55,178)(30,055)(25,512)(16,945)(14,762)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(87,933)(56,241)(55,178)(30,055)(21,561)(20,233)(15,280)
Comprehensive loss:(87,933)(56,241)(55,178)(30,055)(21,561)(20,233)(15,280)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(5)(29)38(4)13,286519
Comprehensive loss, net of tax, attributable to parent:(87,938)(56,270)(55,140)(30,059)(21,560)(16,947)(14,761)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: